Insulet | PODD - Stock


Insulet reported $462.5M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Abbott USD 6.99B 501M Mar/2026
Align Technology USD 214.94M 11.4M Mar/2026
AtriCure USD 81.14M 2.65M Mar/2026
Avanos Medical USD 141.3M 6.7M Mar/2026
Baxter International USD 2.32B 84M Mar/2026
Becton, Dickinson and Co. USD 3.36B 728M Mar/2026
Boston Scientific USD 3.12B 174M Mar/2026
Cardinal Health USD 18.01B 2.11B Mar/2026
Cooper Companies USD 876.4M 30.4M Dec/2025
Dexcom USD 693.6M 64.5M Mar/2026
Edwards Lifesciences USD 1.12B 7.2M Mar/2026
Eli Lilly USD 14.53B 785M Mar/2026
Globus Medical USD 772.6M 13.32M Mar/2026
ICU Medical USD 605.59M 10.27M Mar/2026
Inogen USD 25.08M 762K Sep/2025
Insulet USD 462.5M 9.9M Mar/2026
Integra LifeSciences USD 495.04M 2.3M Mar/2026
J&J USD 14.58B 392M Mar/2026
Medtronic USD 6.31B 153M Dec/2025
Merit Medical Systems USD 352.39M 18.68M Mar/2026
Roche Holding CHF 7.6B 9M Jun/2025
Solventum Corp USD 1.09B 23M Mar/2026
Stryker USD 5.42B 109M Mar/2026
Tandem Diabetes Care USD 126.4M 2.37M Mar/2026
Teleflex USD 380.86M 23.53M Mar/2026
West Pharmaceutical Services USD 452.6M 8.7M Mar/2026
Zimmer Biomet Holdings USD 2.25B 39.6M Mar/2026